返回 Agenda
The Future of Regulatory Documentation with Generative AI
Session Chair(s)
Emmanuel Walckenaer, MS
CEO
YSEOP, France
As the medical writing community manages an unprecedented level of new drug development, what role will Generative AI play moving forward? Increasingly, Biopharma companies are exploring AI to empower their workforces to operate more efficiently while enhancing output quality.
This session looks at how Yseop has partnered with GSK to address their unique content automation requirements. Speakers from GSK will review how AI is impacting clinical document development and the challenges and opportunities with their early experience in the space.
Speaker(s)
The Future of Regulatory Documentation with Generative AI
Eishita Agarwal, MSC
GSK, India
Digital Innovation Manager, Medical Writing